.jpg?format=webp&quality=80&width=3840)
Advanced prenatal genomic technologies can identify risks for adult‐onset (AO) conditions in the fetus, challenging the traditional purpose of prenatal testing. Professional guidelines commonly support disclosure of high‐penetrance AO actionable conditions, yet attitudes of women/parents to these findings and factors affecting their attitudes are understudied. In light of the demonstrated understanding of nuanced genetic information and the observed diversity in perspectives, a culturally competent opt‐in/out policy could be considered. If full disclosure is practiced, support should be provided to those expressing higher levels of distress.
Like
Save
Share